Gonal-F (follitropin alfa for injection)
Company: Serono Laboratories
Approval Status: Approved September 1997
Treatment for: infertility
Areas: Endocrinology; Obstetrics/Gynecology
General Information
Other Useful Resources
Gonal-F (follitropin alfa for injection) has received marketing clearance from the U.S. Food and Drug Administration (FDA). Gonal-F is indicated for ovulation induction and for use in conjunction with assisted reproductive technologies, such as in vitro fertilization.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
